CRISPR/Cas Systems: Biological Basis and Genome Editing Applications.- DNA Repair Mechanisms.- Prime Editing: An Overview.- Base Editing: Mechanisms and Therapeutic Applications.- An Overview of Programmable Epigenetic Editing Based on CRISPR Tools for Gene Expression Regulation.- Overview of Delivery Methods for Gene Editing.- Production of Lentiviral Vectors Encoding the CRISPR-Cas13d System for RNA Targe ...Täielik kirjeldus
CRISPR/Cas Systems: Biological Basis and Genome Editing Applications.- DNA Repair Mechanisms.- Prime Editing: An Overview.- Base Editing: Mechanisms and Therapeutic Applications.- An Overview of Programmable Epigenetic Editing Based on CRISPR Tools for Gene Expression Regulation.- Overview of Delivery Methods for Gene Editing.- Production of Lentiviral Vectors Encoding the CRISPR-Cas13d System for RNA Targeting.- Production and Storage of High-Capacity Adenoviral Vectors for the Delivery of Advanced CRISPR Systems.- Adeno-Associated Viral Vector (AAV)-Mediated In Vivo CRISPR-Cas9 Delivery.- Lipid Nanoparticle-Mediated Delivery of CRISPR–Cas9 Components for Genome Editing.- CRISPR/Cas9 Delivery Using Extracellular Vesicles.- Preparation of Polymeric Nanoparticles for Gene Delivery.- Quantitative Analysis of CRISPR Encoding Plasmid DNA–Nanocarrier Interactions by Gel Electrophoresis and Densitometry.- Cell-Penetrating Peptide Delivery for CRISPR Applications.- Oligo-Modified Poly(β-amino ester)-Mediated mRNA Delivery: A Protocol for Gene Editing Applications.- Virus-Like Particles as a Non-Viral CRISPR/Cas Editing Delivery Tool.- Production and Purification of Cas9 Protein for Ribonucleoprotein Complex Formation.- Electroporation for High-Efficiency Delivery of CRISPR to Hematopoietic Cells.- An Electroporation-Based Protocol for Ex Vivo Base Editing: From Design to Quantitative Assessment.- Nucleofection-Based CRISPR/Cas Delivery in Human T Cells for Immunotherapy Applications.- Delivery of Targeting Constructs into Zygotes Using Electroporation.